RLYB Institutional Ownership

Rallybio Corp

Latest close $16.14 as of Aug 5, 2026

Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices. Form 13F rows are quarter-end holding context only and do not establish an exact entry date.

Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes. Filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro. The overall institutional consensus preview remains public. Compare plans.

Cross-institution intelligence

Institutional Research

Each institution is compared with its own prior filing, then the latest institution-level directions are compared for breadth.

Latest filing Aug 6, 2026

Public consensus preview Accumulation leaning 68/100 institutional research score

1 tracked institution Latest filing Aug 6, 2026

1 accumulating across 1 comparable institution.

Accumulating1

Unchanged0

Reducing0

Exited0

The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.

Price context

52-week position is market context and does not change the institutional consensus score.

52-week low$2.55 52-week high$17.57

Latest close $16.14 90.5% through the range

Tracked institutions

Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.

Latest observation Jun 30, 2026

Fidelity / FMR Aug 6, 2026 filed

Detailed institutional research

See what is driving the consensus.

Unlock holder-by-holder changes, ownership history, breadth by period, disclosure timing, and filing-specific signal analysis.

Create free account Compare Investor and Pro

A free account adds watchlists and reveals tracker research gauges. Investor or Pro unlocks the detailed research above.

Beneficial ownership filing history

Showing 3 of 3 parsed filing(s)

Holder	Observed / filed	Reported change	Shares	Ownership	Observation	Filing	Latest
Fidelity / FMR CIK0000315066	Jun 30, 2026 observed Aug 6, 2026 filed · 37d Schedule 13G amendment	Reported accumulation	794.7K +232.9K	15.00% +3.00 pts	$16.00	$16.20	$16.14
Fidelity / FMR CIK0000315066	Mar 4, 2026 observed Mar 6, 2026 filed · 2d Schedule 13G amendment	Reported accumulation	561.8K +189.0K	12.00% 0.00 pts	$10.51	$10.91	$16.14
Fidelity / FMR CIK0000315066	Mar 2, 2026 observed Mar 6, 2026 filed · 4d Initial Schedule 13G	Initial Schedule 13G	372.8K	12.00%	$10.97	$10.91	$16.14

Explore more institutional activity

Related research

Crawlable links to other securities with similar institutional consensus or recent multi-institution accumulation.

Similar research strength

ASST STRIVE INC-A 68/100 Accumulation leaning SSD SIMPSON MANUFACTURING CO INC 68/100 Accumulation leaning TXT TEXTRON INC 68/100 Accumulation leaning NKTR NEKTAR THERAPEUTICS 68/100 Accumulation leaning

Recent multi-institution accumulation

TVTX Travere Therapeutics, Inc. 2 accumulating Aug 6, 2026 PCVX VAXCYTE INC 2 accumulating Aug 6, 2026 VVX V2X INC 2 accumulating Aug 6, 2026 VSEC VSE CORP 3 accumulating Jul 31, 2026